LVMH bets on AI to revolutionize anti-aging cosmetics

According to the press release, under the terms of the multi-year agreement, the two companies will pool their expertise and work to discover ‘new chemical entities that target aging at the molecular level.’

The goal will be achieved using Integrated Biosciences' AI-based synthetic biology and artificial intelligence platform. ‘Our partnership with Integrated Biosciences perfectly embodies our vision: to push back the boundaries of scientific discovery in the service of innovation in beauty’, said Bruno Bavouzet, President of LVMH Recherche.

This research and innovation structure, fully integrated into LVMH, can now count on five international sites: the research center at Saint-Jean-de-Braye, near Orléans, where 500 people are employed, and the other headquarters located in Paris, Shanghai, Tokyo, and Seoul. This research giant is acquiring increasing importance in the cosmetics world by moving closer to biotechnologies.

‘By combining our expertise in skin research with their research into AI and aging, we are taking a decisive step forward in the understanding and molecular approach to age-related cellular pathways,’ continued Bavouzet, commenting on the agreement.

The Californian company Integrated Biosciences was founded by scientists from MIT, Harvard University, and the University of California at Santa Barbara. It recently launched a fundraising campaign led by US private equity firm Sutter Hill Ventures, with the aim of developing - with the help of artificial intelligence - research into senolytics (substances derived from plants that have properties used in aging medicine).

‘This collaboration with LVMH Recherche represents a significant step forward in our shared commitment to fighting aging through cutting-edge science,’ added Felix Wong, co-founder, and CEO of Integrated Biosciences.

Depending on the discoveries made, the Californian company could receive several amounts from LVMH. Figures for the agreement have not been revealed, and the commercial stages of the partnership remain secret.